R.H. Dinel Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.98M | Hold |
17,921
| – | – | 6.9% | 3 |
|
|
2026
Q1 | $8.81M | Hold |
17,921
| – | – | 7.13% | 3 |
|
|
2025
Q4 | $10.4M | Sell |
17,921
-1,825
| -9% | -$1.03M | 7.61% | 3 |
|
|
2025
Q3 | $9.58M | Hold |
19,746
| – | – | 6.18% | 4 |
|
|
2025
Q2 | $8.01M | Sell |
19,746
-585
| -3% | -$245K | 5.34% | 7 |
|
|
2025
Q1 | $10.1M | Hold |
20,331
| – | – | 6.9% | 2 |
|
|
2024
Q4 | $10.6M | Buy |
20,331
+950
| +5% | +$522K | 7.06% | 3 |
|
|
2024
Q3 | $12M | Hold |
19,381
| – | – | 7.49% | 3 |
|
|
2024
Q2 | $10.7M | Hold |
19,381
| – | – | 6.86% | 4 |
|
|
2024
Q1 | $11.3M | Hold |
19,381
| – | – | 7.2% | 3 |
|
|
2023
Q4 | $10.3M | Sell |
19,381
-250
| -1% | -$121K | 7.03% | 3 |
|
|
2023
Q3 | $9.94M | Hold |
19,631
| – | – | 7.17% | 3 |
|
|
2023
Q2 | $10.2M | Sell |
19,631
-200
| -1% | -$108K | 7.17% | 3 |
|
|
2023
Q1 | $11.4M | Buy |
19,831
+875
| +5% | +$493K | 8.6% | 2 |
|
|
2022
Q4 | $10.4M | Hold |
18,956
| – | – | 9.34% | 2 |
|
|
2022
Q3 | $9.61M | Sell |
18,956
-425
| -2% | -$238K | 9.57% | 2 |
|
|
2022
Q2 | $10.5M | Hold |
19,381
| – | – | 9.48% | 2 |
|
|
2022
Q1 | $11.4M | Sell |
19,381
-3,309
| -15% | -$1.9M | 8.81% | 2 |
|
|
2021
Q4 | $15.1M | Hold |
22,690
| – | – | 10.41% | 2 |
|
|
2021
Q3 | $13M | Sell |
22,690
-1,163
| -5% | -$638K | 9.72% | 2 |
|
|
2021
Q2 | $12M | Hold |
23,853
| – | – | 8.58% | 3 |
|
|
2021
Q1 | $10.9M | Sell |
23,853
-175
| -0.7% | -$83.5K | 8.32% | 2 |
|
|
2020
Q4 | $11.2M | Hold |
24,028
| – | – | 9% | 3 |
|
|
2020
Q3 | $9.95M | Hold |
24,028
| – | – | 9.49% | 3 |
|
|
2020
Q2 | $8.71M | Hold |
24,028
| – | – | 8.47% | 3 |
|
|
2020
Q1 | $6.81M | Sell |
24,028
-150
| -0.6% | -$47.3K | 8.06% | 3 |
|
|
2019
Q4 | $7.86M | Sell |
24,178
-925
| -4% | -$280K | 6.95% | 3 |
|
|
2019
Q3 | $7.31M | Sell |
25,103
-265
| -1% | -$75.9K | 6.8% | 2 |
|
|
2019
Q2 | $7.45M | Sell |
25,368
-750
| -3% | -$207K | 6.9% | 2 |
|
|
2019
Q1 | $7.15M | Sell |
26,118
-150
| -0.6% | -$37.3K | 7.07% | 1 |
|
|
2018
Q4 | $5.88M | Buy |
+26,268
| New | +$6.16M | 6.61% | 1 |
|
|
2016
Q3 | $5.31M | Buy |
33,368
+650
| +2% | +$100K | 5.94% | 2 |
|
|
2016
Q2 | $4.83M | Hold |
32,718
| – | – | 5.66% | 2 |
|
|
2016
Q1 | $4.63M | Hold |
32,718
| – | – | 5.44% | 3 |
|
|
2015
Q4 | $4.64M | Sell |
32,718
-8,025
| -20% | -$1.07M | 5.26% | 2 |
|
|
2015
Q3 | $4.98M | Hold |
40,743
| – | – | 5.2% | 2 |
|
|
2015
Q2 | $5.29M | Hold |
40,743
| – | – | 4.95% | 2 |
|
|
2015
Q1 | $5.47M | Hold |
40,743
| – | – | 5.14% | 2 |
|
|
2014
Q4 | $5.11M | Hold |
40,743
| – | – | 4.54% | 3 |
|
|
2014
Q3 | $4.96M | Hold |
40,743
| – | – | 4.49% | 3 |
|
|
2014
Q2 | $4.81M | Sell |
40,743
-1,150
| -3% | -$135K | 4.38% | 3 |
|
|
2014
Q1 | $5.04M | Hold |
41,893
| – | – | 4.45% | 3 |
|
|
2013
Q4 | $4.67M | Buy |
+41,893
| New | +$4.17M | 4.1% | 3 |
|
Other funds holding TMO
RG
VAM
R.H. Dinel Investment Counsel's TMO Position: Q2 2026 in Review
R.H. Dinel Investment Counsel held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 17,921 shares worth $8.98M. The position accounts for 6.9% of the portfolio, ranked #3.
R.H. Dinel Investment Counsel first reported a position in TMO in Q4 2013 and has held it in 43 quarters since. The position peaked at $15.1M in Q4 2021. 1,512 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- R.H. Dinel Investment Counsel held 17,921 shares of Thermo Fisher Scientific worth $8.98M as of Q2 2026.
- R.H. Dinel Investment Counsel left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 6.9% of R.H. Dinel Investment Counsel's portfolio in Q2 2026, its #3 holding.
- R.H. Dinel Investment Counsel first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 43 quarters since.
- R.H. Dinel Investment Counsel's Thermo Fisher Scientific position peaked at $15.1M in Q4 2021.
- 1,512 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on R.H. Dinel Investment Counsel's 13F filing for Q2 2026, filed 13 Jul 2026.